• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS SMART PORT; PORT & CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS SMART PORT; PORT & CATHETER Back to Search Results
Model Number CT66LTPD
Device Problems Difficult to Remove (1528); Obstruction of Flow (2423)
Patient Problem Infiltration into Tissue (1931)
Event Date 09/06/2022
Event Type  malfunction  
Event Description
It was reported that the patient was at end of therapy when they identified the line was blocked.When removing the device, the surgeon reportedly observed a "tissue reaction" on the patient.The "line" (catheter) was mentioned to be "blocked" and hence the decision for the removal of the port was made.The doctor made a primary incision for the removal/explant of the port.It was reported that when the pocket was opened, the catheter would not pull out of the tunnel.Therefore, "many more" than usual additional incisions were required on the neck to approach the catheter from another angle in order to successfully remove the device.Details of the removal procedure are as follows: elective admission for removal of right internal jugular vein port as end of therapy.Incision through previous scar adjacent to port.Dissection and mobilisation of port using diathermy, and removal of prolene stay suture.Traction to catheter to attempt to remove, but significant resistance encountered, and tethering of catheter noted to subcutaneous tissues along the tract of the catheter.Dissection around catheter attempted, but catheter still fixed within subcutaneous tissues, and at neck.Previous neck incision opened, further dissection at this site to mobilise catheter allowed the catheter to then be retrieved from the internal jugular vein, but catheter still required significant dissection along subcutaneous tract in order to mobilise, and with persistent tethering still noted further along the subcutaneous tract, a 3rd incision then required along the chest wall (approximately mid-way between neck incision and port site incision) in order to mobilise the catheter/dissect it free from subcutaneous tissues.Hence why catheter was then cut into pieces as part of the removal process.Of note the catheter appeared "rough" and appeared to have fibrous ingrowth along its length, which is not what the provider usually encounters with port catheter removals, as usually the catheter slides freely out from a fibrous sheet and appears clean/white after its removal.The line did not snap, but it would have snapped or broken if more traction was applied to remove it.The line did not just "slide out" from the tissues as they usually would, and there was clearly ingrowth of fibrous tissue along the length of the catheter and not just at the insertion site into the vein or at the suture site of the port.The line is in pieces however because the provider had to cut it and remove it from the patient via 3 separate incisions with dissection along the catheter through each of these separate incisions in order to mobilise it free from her tissues.There were actually 2 additional incisions (and 3 incisions in total) to remove this device (whereas usually only 1 incision - over the port is required).For this patient, in addition to the incision over the port, she did require the neck incision, and additionally a 3rd incision over the chest wall (at a point approximately midway between the neck and port site incisions, in order to further dissect/mobilise the catheter free from the subcutaneous tissues.Without this 3rd incision the catheter would have snapped or broken and would not have been totally removed from the patient.The only complication was the requirement of an additional (3rd) skin incision in order to remove the device.And a slightly longer anaesthetic than would usually be required for a port removal (anaesthetic time was approximately 1 hour 30mins).
 
Manufacturer Narrative
The reported defective device has been returned to the manufacturer and an investigation into the root cause for event is currently in progress.The results of the investigation will be sent via a follow up medwatch.Reference (b)(4).
 
Manufacturer Narrative
Returned for evaluation was one (1) smartport.As received, approximately 7cm of catheter tubing was attached to the port.The customer returned approximately 13cm of catheter tubing.  the catheter tubing attached to the port also contained a kink at the 3cm mark.The port and catheter tubing were occluded with bio material {blood}.The customer's reported complaint description of port catheter tubing occluded was confirmed based on evaluation of the returned port and catheter tubing as received; lumen occluded with dried blood, but this is expected for a returned used device.The reported complaint of catheter difficult to remove was confirmed as the exterior of the catheter tubing (portion near port device that would be in tunneled area) had a rough surface indicating it was adhered to tissue.Although the reported complaint description is confirmed, a definitive root cause cannot be determined.The returned catheter was observed to have rough surface on the exterior of the catheter near the port housing and tunneled area. this most likely contributed to the difficult to remove catheter event experienced during the port explant procedure.However, we are unable to determine an exact root cause for the rough exterior surface.  no manufacturing related non-conformances were observed during evaluation of the returned port/catheter tubing.   a review of the device history records was performed for the reported packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly, and performance specifications.Labeling review: the instructions for use, which is supplied to the user with this catalog number, contains the following statements: absence of a blood return or a poor blood return can be a sign of a potential complication such as occlusion, kinking, breakage, pinch-off syndrome, fibrin formation, thrombosis or malposition.This should be evaluated prior to device usage.A blood return should be present prior to usage of device for any therapy or testing.If the patient complains of pain, or if there is swelling when the device is flushed or when medication or contrast media is administered, evaluate the device for infiltration, proper needle placement, and potential complications such as occlusion, kinking, breakage, pinch-off syndrome, thrombosis or malposition.Failure to assess these complaints or observations can lead to device failure.Caution: avoid piercing catheter with suture needle.Potential complications: catheter fragmentation and catheter pinch-off.Catheter placement considerations: warning: avoid medial catheter placement into sub-clavian vein through percutaneous technique.This placement could lead to catheter occlusion, damage, rupture, shearing, or fragmentation due to compression of the catheter between the first rib and clavicle.Catheter shearing has been reported when the catheter is inserted via a more medial route in the subclavian vein.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART PORT
Type of Device
PORT & CATHETER
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls, ny 12801 NY 12801
Manufacturer (Section G)
ANGIODYNAMICS
10 glens falls technical park
glens falls, ny 12801 NY 12801
Manufacturer Contact
alexandra invencio
26 forest street
marlborough, MA 01752
5086587805
MDR Report Key15561367
MDR Text Key307024269
Report Number1317056-2022-00122
Device Sequence Number1
Product Code LJT
UDI-Device IdentifierH787CT66LTPD0
UDI-PublicH787CT66LTPD0
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K101017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 12/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberCT66LTPD
Device Catalogue NumberCT66LTPD
Device Lot Number5397469
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/04/2022
Initial Date Manufacturer Received 09/15/2022
Initial Date FDA Received10/07/2022
Supplement Dates Manufacturer Received12/14/2022
Supplement Dates FDA Received12/16/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/19/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age6 YR
Patient SexFemale
-
-